Home  /  About Us  /  News  /  Strides in Science

For all media inquiries, or for more information about the AADOCR, please contact:

Elise Bender
Marketing & Communications Manager


Stay up to date on the latest news at AADR by reading our press releases. Use the search and keyword features on the left to sort past press releases. 

Salomon Amar - December 2015

0 2720

Salomon Amar, D.D.S., D.M.D., Ph.D., is director, Center for Anti-inflammatory Therapeutics, Boston University, Massachusetts. There, he is also a professor in the School of Dental Medicine, Department of Molecular & Cell Biology and the Department of Periodontology. 

Amar earned a B.S. in mathematics and physics from Aquiba School, Strasbourg, France. Afterward, he went on to earn a D.D.S., a certificate in histology cytology, an M.S. in skeletal tissues and apatites, a certificate in periodontology and a Ph.D. in developmental biology from Université Louis Pasteur, France. Afterward he relocated to the U.S. and continued his education as a postdoc fellow in biochemistry-molecular biology at Northwestern University, Chicago; going on to earn a certificate in periodontology from Eastman Dental Center, Rochester, N.Y. and a D.M.D. from Boston University.

Indu S. Ambudkar - November 2015

0 2798

Indu S. Ambudkar, Ph.D., is chief, Molecular Physiology and Therapeutics Branch and Secretory Physiology Section at the National Institute of Dental and Craniofacial Research. She earned her B.Sc. and M.Sc. from Isabella Thoburn College, Lucknow, India; and her Ph.D. from Madurai Kamaraj University, Madurai, India.  

Ambudkar has significantly contributed toward establishing the role of Ca2+ in the salivary secretory process as well as dysfunctions due to radiation and immune disorders. Her studies suggest a link between reduced levels of key Ca2+ signaling proteins and the development of Sjogren’s Syndrome. Her studies demonstrate that in salivary glands the channel protein Transient Receptor Potential Melastatin-like 2, a Ca2+-permeable non selective cation channel, contributes to loss of salivary gland function during radiation and oxidative stress. Consequently, reducing the function of this cation channel, could protect the glands from the deleterious effects of radiation. 

Dean Ho - October 2015

0 2915

Dean Ho, Ph.D. is a professor in the Division of Oral Biology and Medicine and co-director of the Jane and Jerry Weintraub Center for Reconstructive Biotechnology at the University of California – Los Angeles (UCLA) School of Dentistry. He is also a professor of bioengineering and a member of the Jonsson Comprehensive Cancer Center and California NanoSystems Institute. Previously he was an associate professor of biomedical engineering and mechanical engineering at Northwestern University.  

Ho received his Ph.D. in biomedical engineering from UCLA. Today he leads one of the pre-eminent teams in the world that is developing nanodiamonds as drug delivery agents, and has pioneered multiple approaches towards improved therapeutic efficiency using engineering and nanotechnology-based approaches. In the area of chemotherapy, his team developed NDX, a nanodiamond-drug complex based upon the potent interaction of the diamond surface with doxorubicin, a commonly used cancer drug in the clinic that is also highly toxic. Through the synthesis of NDX, a marked enhancement in drug efficacy and reduced toxicity were demonstrated over clinical standards. 

Ronald Dubner - September 2015

0 3056

Ronald Dubner, D.D.S., Ph.D. is professor in the Department of Neural and Pain Sciences at the University of Maryland School of Dentistry. He holds an adjunct faculty appointment in the Department of Anatomy and Neurobiology at the University of Maryland, School of Medicine. Dubner has a D.D.S. degree and a Ph.D. in physiology and has utilized both degrees throughout a research career in the area of pain and neuroscience and their relevance to orofacial health and disease.

For 13 years until 2008, Dr. Dubner was chair of the Department of Biomedical Sciences at the University of Maryland, which he organized and developed into a major basic science and clinical research department that consisted of over 100 faculty, staff, postdoctoral fellows and graduate students engaged in research and teaching. This group conducted research in the fields of pain and neuroscience, immune function and infectious disease, and molecular and cellular oncology, and now has been reorganized into three independent departments in the School of Dentistry. Before 1995, for three decades, he was a scientist in the intramural program of the National Institutes of Health, Bethesda, Maryland, where he directed a multidisciplinary program of over 30 basic and clinical scientists who conducted research on pain mechanisms and pain control.  

Alexandre DaSilva - August 2015

0 2634

Alexandre DaSilva, D.D.S., D.Med.Sc., is an assistant professor at the Biologic & Materials Sciences Department at the University of Michigan School of Dentistry. There, he is also the director of H.O.P.E. (Headache & Orofacial Pain Effort), which is a multidisciplinary collaborative effort to investigate the brain as a research and therapeutic target for chronic trigeminal pain disorders.

He received his Doctorate in Medical Science degree in oral biology with clinical training in TMD and orofacial pain at Harvard University. His thesis subject was on somatotopic (fMRI) activation in the human trigeminal pain pathway. This training was followed by a post-doctoral fellowship on migraine neuroimaging at the Martinos Center for Biomedical Imaging, Massachusetts General Hospital, to investigate subcortical and cortical neuroplasticity in migraine patients. He also worked in the Psychiatric Department at Harvard University/McLean Hospital, and was an assistant clinical investigator at The Forsyth Institute in Boston. During his training, he collaborated with his colleagues on innovative neuroimaging and non-invasive brain stimulation projects for chronic TMD, trigeminal neuropathic pain and migraine.


Theme picker